Growth Failure Due to Severe Insulin-like Growth Factor-1 Deficiency
📧 Sign up to get email alerts when something new happens for Growth Failure Due to Severe Insulin-like Growth Factor-1 Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-03-15FDA Approved: INCRELEX — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
The FDA approved a supplemental application for INCRELEX (mecasermin) from Ipsen Biopharmaceuticals, Inc.
-
FDA approval · 2013-01-16FDA Approved: INCRELEX — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
FDA approved a supplemental application for INCRELEX (mecasermin) submitted by Ipsen Biopharmaceuticals, Inc.